Biogened S.A. (WSE:BGD)
Poland flag Poland · Delayed Price · Currency is PLN
19.10
0.00 (0.00%)
At close: Mar 5, 2026

Biogened Income Statement

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
114.04110.9395.5679.6265.32
Revenue Growth (YoY)
2.80%16.09%20.02%21.89%35.15%
Cost of Revenue
4134.2832.0722.1823
Gross Profit
73.0476.6563.4957.4442.32
Selling, General & Admin
63.766.8854.6241.8635.29
Other Operating Expenses
0.230.720.77.22.43
Operating Expenses
63.9367.655.3249.0637.73
Operating Income
9.119.068.168.384.59
Interest Expense
-2.21-2.37-2.16-1.7-0.6
Interest & Investment Income
-0000.01
Other Non Operating Income (Expenses)
-0.43-0.170-0.32-0.16
EBT Excluding Unusual Items
6.486.526.016.363.84
Gain (Loss) on Sale of Investments
----0.49
Gain (Loss) on Sale of Assets
0.420.320.880.03-0
Other Unusual Items
-0.85---
Pretax Income
6.97.696.896.394.33
Income Tax Expense
2.281.871.793.012.37
Net Income
4.625.825.13.381.96
Net Income to Common
4.625.825.13.381.96
Net Income Growth
-20.59%14.22%50.74%72.46%57.92%
Shares Outstanding (Basic)
22222
Shares Outstanding (Diluted)
22222
EPS (Basic)
1.882.372.081.380.80
EPS (Diluted)
1.882.372.081.380.80
EPS Growth
-20.59%14.22%50.74%72.46%57.92%
Free Cash Flow
5.13-1.497.72-3.351.57
Free Cash Flow Per Share
2.09-0.613.14-1.360.64
Dividend Per Share
-0.5000.5000.400-
Dividend Growth
--25.00%--
Gross Margin
64.05%69.10%66.44%72.14%64.78%
Operating Margin
7.99%8.16%8.54%10.52%7.03%
Profit Margin
4.05%5.25%5.33%4.25%3.00%
Free Cash Flow Margin
4.50%-1.35%8.08%-4.21%2.41%
EBITDA
13.4913.1911.6911.317.47
EBITDA Margin
11.82%11.89%12.23%14.21%11.44%
D&A For EBITDA
4.374.133.522.942.88
EBIT
9.119.068.168.384.59
EBIT Margin
7.99%8.16%8.54%10.52%7.03%
Effective Tax Rate
33.00%24.33%26.01%47.09%54.71%
Revenue as Reported
114.04110.9395.5679.6265.32
Source: S&P Global Market Intelligence. Standard template. Financial Sources.